• SENSEX 79,212.53
    -588.90 (--0.74%)
  • BANKNIFTY 54,664.05
    -537.35 (--0.97%)
  • Reliance Industr
    1,288.00 1,115.55(%)
  • ITC
    423.35 381.24(%)
  • Trent
    5,106.40 4,058.45(%)
  • Hind. Unilever
    2,339.45 3,034.50(%)
  • Larsen & Toubro
    3,231.30 2,967.65(%)
  • Asian Paints
    2,413.50 2,125.00(%)
  • Ambuja Cements
    544.50 452.90(%)
  • Atul
    6,566.00 8,165.25(%)
  • ACC
    1,930.00 1,778.80(%)
  • Reliance Infra.
    250.50 143.70(%)
  • M & M
    2,831.30 2,001.00(%)
  • Hind.Construct.
    25.51 21.37(%)
  • MRF
    127,450.00 100,500.00(%)
  • Nestle India
    2,387.80 2,115.00(%)
  • PCBL Chemical
    379.15 208.80(%)
  • Hindalco Inds.
    612.90 546.25(%)
  • Force Motors
    8,860.00 6,128.55(%)
  • Indian Hotels Co
    770.20 507.45(%)
  • Kirl.Pneumatic
    1,144.70 790.15(%)
  • Exide Inds.
    367.05 327.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Lupin Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3026.0
  • ISIN : INE326A01037
2,019.60 -85 (-4.02%)
  • As on 25 Apr 2025 (EOD)
  • Today’s Low

    2,011.20
  • Today’s High

    2,124.90
  • Open

    2,110.80
  • Perv Close

    2,104.10
  • 52W Low

    0.00
  • 52W High

    0.00

Key Indicators

  • P/E(TTM)

    29.46

  • Mar.Cap (₹Cr.)

    92,207.88

  • Div & Yield %

    0.40

  • Book Value(₹)

    481.38

  • Debt-Equity Ratio

    -4.02

  • AGM Date

    25-Apr-2025

  • EPS

    68.52

  • P/E Ratio

    29.46

Financials Ratios

  • Debt-Equity Ratio

    0.28

  • Mar.Cap (₹Cr.)

    92,207.88

  • RONW (%)

    14.47

  • ROCE (%)

    15.34

Score Board

  • Equity (₹ in Cr.)

    91.31

  • BV (₹)

    481.40

  • Sales( ₹ in Cr.)

    14,666.50

  • NP (in Cr.)

    2,302.84

  • NP Var(%)

    461.0

  • Div%

    400.0

  • CPS (₹)

    66.30

  • EPS (₹)

    50.40

  • Traded Value (₹ in Lakhs)

    96,102.38

  • 52 Week High

    0.00

  • 52 Week Low

    0.00

  • Price BSE

    2105.0

  • Price NSE

    2,104.00

  • Market Capital( in Cr.)

    96,102.38

  • P/C Ratio

    31.70

  • P/E Ratio

    41.70

  • Price Vs.BV

    50.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 14,666.50 11,258.83 11,771.67 11,055.93 11,025.66 11,356.32
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 14,666.50 11,258.83 11,771.67 11,055.93 11,025.66 11,356.32
Other Income 115.51 210.02 216.99 129.09 475.19 291.34
Stock Adjustments 15.93 -120.79 242.38 81.86 28.72 147.23
Total Income 14,797.94 11,348.06 12,231.04 11,266.88 11,529.57 11,794.89
EXPENDITURE :            
Raw Materials 5,041.16 4,676.90 4,709.64 4,264.17 4,235.99 4,040.13
Power and Fuel Cost 444.41 447.42 418.45 389.54 416.26 416.30
Employee Cost 2,095.51 1,934.14 1,918.16 1,695.86 1,703.22 1,515.42
Other Manufacturing Expenses 1,182.52 1,155.60 1,209.09 1,135.79 1,108.70 1,050.87
Selling and Administration Expenses 2,268.24 1,797.13 1,573.22 1,355.01 1,557.70 1,488.58
Miscellaneous Expenses 200.31 162.95 1,976.35 253.36 884.11 479.45
Employee Benefit Expenses 2,095.51 1,934.14 1,918.16 1,695.86 1,703.22 1,515.42
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 11,232.15 10,174.14 11,804.91 9,093.73 9,905.98 8,990.75
Operating Profit 3,565.79 1,173.92 426.13 2,173.15 1,623.59 2,804.14
Interest 56.35 98.44 73.47 40.62 52.59 35.47
Gross Profit 3,509.44 1,075.48 352.66 2,132.53 1,571.00 2,768.67
Depreciation 724.75 548.34 514.19 502.83 518.75 426.30
Profit Before Tax 2,784.69 527.14 -161.53 1,629.70 1,052.25 2,342.37
Current Tax 484.05 95.89 57.80 362.85 362.05 795.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -25.45 6.04 -30.63 8.23 -37.35 8.54
Reported Net Profit 2,326.09 425.21 -188.70 1,258.62 727.55 1,538.83
Extraordinary Items 23.25 14.42 30.64 41.61 -425.63 -205.15
Adjusted Net Profit 2,302.84 410.79 -219.34 1,217.01 1,153.18 1,743.98
Adjustment below Net Profit -8.79 -1.39 2.42 -7.89 -135.66 -46.47
P & L Balance brought forward 15,274.71 15,032.74 15,514.10 14,535.25 14,227.34 12,961.06
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 258.04 181.85 295.08 271.88 226.30 226.08
P & L Balance carried down 17,333.97 15,274.71 15,032.74 15,514.10 14,592.93 14,227.34
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 400.00 200.00 200.00 325.00 300.00 250.00
Dividend Per Share(Rs) 8.00 4.00 4.00 6.50 6.00 5.00
Earnings Per Share-Unit Curr 51.04 9.35 -4.15 27.74 16.06 34.01
Earnings Per Share(Adj)-Unit Curr 51.04 9.35 -4.15 27.74 16.06 34.01
Book Value 452.12 404.66 399.34 409.20 385.72 378.28
Book Value(Adj)-Unit Curr 452.12 404.66 399.34 409.20 385.72 378.28

Shareholding Pattern

  • Promoter Group

    46.92%

  • Public Share Holding

    53.08%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 1,286,394 1,286,394.00 1,286,394 1,286,394
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 1,286,394 0.28 1,286,394 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 207,194,390 45.38 207,194,390 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,725,730 1.25 5,725,730 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 1,000 0.00 1,000 1
Others 0 0.00 0 0
Sub Total 212,921,120 46.64 212,921,120 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 36,052 0.01 36,052 3
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 7,200 0.00 5,700 8
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 97,986,448 21.46 97,986,448 872
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 28,953,262 6.34 28,953,262 30
Mutual Funds / UTI 80,107,546 17.55 80,104,946 38
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 6,937,604 1.52 6,937,604 28
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 214,028,112 46.88 214,024,012 979
2] Non Institution
Bodies Corporate 1,347,379 0.30 1,341,379 1,092
Clearing Members 1,656 0.00 1,656 13
Directors of their Relatives 27,232 0.01 27,232 1
Employees 3,800 0.00 0 4
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 5,000 0.00 5,000 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,751,813 0.38 1,751,413 8,395
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 538,819 0.12 538,819 3,891
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 264,800 0.06 264,800 2
Individuals holding nominal share capital up to Rs. 1 lakh 23,023,833 5.04 22,505,142 268,697
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 12,978 0.00 12,978 17
Others 1,231,508 0.27 1,231,508 4
Sub Total 28,329,419 6.20 27,799,328 282,219
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 456,565,045 100.00 456,030,854 283,210

Company Background

Lupin LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Lupin Ltd
  • BSE Code : 3026.0
  • ISIN : INE326A01037
  • Incorporation Year

    1983

  • Registered Office

    Kalpataru Inspire 3rd Floor
    Off Western Exp HW Santacruz-E, Mumbai,
    Maharashtra-400055

  • Telephone

    91-22-6640 2323

  • FAX

    91-22-6640 8131

  • Chairman

    M D Gupta

  • Managing Director

    Nilesh Deshbandhu Gupta.

  • Company Secretary

    R V Satam

  • Auditor

    B S R & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Lupin Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Lupin 2,018.35 14,782.01 14,666.50 30.06 13.96
Abbott India 29,747.90 6,097.18 5,848.91 47.37 44.71
Astrazeneca Phar 8,728.45 1,330.33 1,295.53 225.02 33.26
P & G Health Ltd 5,074.25 1,166.89 1,151.26 35.60 39.76
Glaxosmi. Pharma 2,804.05 3,530.73 3,407.25 55.76 44.44
Cipla 1,525.50 17,645.00 16,574.34 26.15 20.10
Amrutanjan Healt 656.65 437.58 421.23 38.49 20.84
Guj. Themis Bio. 283.70 174.19 169.82 58.74 44.82
Fermenta Biotec. 278.75 315.24 307.09 26.42 4.10
Bliss GVS Pharma 122.05 638.96 605.46 27.93 11.19
Ambalal Sarabhai 37.95 11.70 3.81 16.22 1.92